Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla BioMarin Pharmaceutical Inc.
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
2,817.59 |
3,139.00 |
3,450.73 |
3,744.36 |
4,011.57 |
4,140.34 |
| Przychód Δ r/r |
0.00% |
11.41% |
9.93% |
8.51% |
7.14% |
3.21% |
| Przychód (min) |
2,797.61 |
3,015.09 |
3,195.97 |
3,743.71 |
3,834.56 |
3,957.65 |
| Przychód (max) |
2,827.58 |
3,273.23 |
3,703.33 |
3,745.00 |
4,195.00 |
4,329.66 |
| EBITDA (średnia) |
285.60 |
318.18 |
349.77 |
379.54 |
406.62 |
419.67 |
| EBIT (średnia) |
149.78 |
166.87 |
183.44 |
199.05 |
213.26 |
220.10 |
| EBIT % |
5.32% |
5.32% |
5.32% |
5.32% |
5.32% |
5.32% |
| Zysk netto (średni) |
444.77 |
686.09 |
848.46 |
1,016.88 |
1,242.76 |
1,370.56 |
| Zysk netto % |
15.79% |
21.86% |
24.59% |
27.16% |
30.98% |
33.10% |
| EPS (średnia) |
2.26 |
3.49 |
4.18 |
5.24 |
6.32 |
6.97 |
| Liczba analityków (Przychody) |
22 |
18 |
26 |
19 |
8 |
10 |
| Liczba analityków (EPS) |
18 |
18 |
20 |
14 |
7 |
8 |
| symbol |
BMRN |
BMRN |
BMRN |
BMRN |
BMRN |
BMRN |